LambdaVision Inc Profile last edited on: 8/7/2020
CAGE: 5KMK3
UEI: SJTNSW7KD295
Business Identifier: Retinal implant to restore vision 
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
400 Farmington Avenue
Farmington, CT 06032
Farmington, CT 06032
| (860) 486-6593 |
| info@lambdavision.com |
| www.lambdavision.com |
Location: Multiple
Congr. District: 05
County: Hartford
Congr. District: 05
County: Hartford
Public Profile
With close ties to University of Connecticut, LambdaVision isorganized around the design and development of an innovative, protein-based retinal implant that utilizes the light-activated protein, bacteriorhodopsin, to stimulate the retina of patients suffering from impaired vision or loss of sight due to retinal degenerative diseases, including age-related macular degeneration (AMD) and retinitis pigmentosa (RP). Current treatments of RP and AMD only slow disease progression. LambdaVision is dedicated to creating a retinal prosthesis that is capable of restoring high-resolution vision and enhancing the quality of life for those afflicted by retinal degeneration.
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
5-9Revenue Range
.5M-1MVC funded?
YesPublic/Private
Privately HeldStock Info
----IP Holdings
N/AAwards Distribution by Agency
Most Recent SBIR Projects
| Year | Phase | Agency | Total Amount | |
|---|---|---|---|---|
| 2023 | 1 | NASA | $156,479 | |
| Project Title: Feasibility study for an automated Machine Learning analytics platform for better process control of artificial retina in-space manufacturing | ||||
| 2023 | 1 | NASA | $149,969 | |
| Project Title: On-Orbit Solution Recycling Methods to Improve Scale of Layer-by-Layer Artificial Retina Manufacturing | ||||
| 2020 | 2 | NASA | $871,144 | |
| Project Title: Optimization of the Manufacturing Parameters for the Assembly of Protein-Based Retinal Implants in Microgravity | ||||
| 2020 | 2 | NSF | $1,227,008 | |
| Project Title: Development of a Protein-Based Retinal Implant | ||||
| 2014 | 1 | NIH | $190,499 | |
| Project Title: Flexible Ion-Mediated Artificial Retina | ||||
Key People / Management
Nicole L Wagner -- President and Chief Executive Officer
Constance R Birge -- Adminstrative Specialist
Robert Richards Birge -- Founder
Jordan A Greco -- Director of Operations
Maximilian Vargas -- Director Of Commercial Strategy and Market Access
Constance R Birge -- Adminstrative Specialist
Robert Richards Birge -- Founder
Jordan A Greco -- Director of Operations
Maximilian Vargas -- Director Of Commercial Strategy and Market Access
Company News
There are no news available.
